Experts share how roluperidone provides a new opportunity in the schizophrenia treatment landscape.
Michael Davidson, MD
Advertisement
Articles by Michael Davidson, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
2
FDA Issues CRL for CTx-1301 for Treatment of ADHD
3
Adjunctive Atypical Antipsychotics in Major Depressive Disorder: Comparing Efficacy and Tolerability
4
Endangered Education: Psychiatric Professional Degrees Under Attack
5